Skip to main content
. 2024 Jan 4;34(7):4273–4283. doi: 10.1007/s00330-023-10516-3

Table 1.

Participants’ characteristics and stent information

Characteristics Values
Participant characteristics
Number of participants 18 (100%)
Age (years) 82.6 ± 5.9
Sex
    Females 12 (66.7%)
    Males 6 (33.3%)
  Weight (kg) 74.4 ± 11.4
  BMI (kg/m2) 25.7 ± 3.0
Cardiovascular risk factors
History of myocardial ischemia 3 (16.7%)
History of coronary stenting 18 (100%)
Arterial hypertension 13 (72.2%)
Diabetes mellitus 7 (38.9%)
Hyperlipidemia 15 (83.3%)
Chronic kidney disease (eGFR < 45 mL/min/1.73 m2) 7 (38.9%)
Smoking 6 (33.3%)
  Tube voltage
    120 kV 8 (44.4%)
    140 kV 10 (55.6%)
  Radiation dose
    CTDIvol (mGy) 70.2 [64.9–80.9]
    DLP (mGy*cm) 994 [878–1086]
Stent information
Number of stents 44 (100%)
Location
    LM 2 (4.5%)
    LAD 17 (36.4%)
    LCx 14 (29.5%)
    RCA 11 (22.7%)
  Diameter
    > 3 mm 31 (70.4%)
    ≤ 3 mm 13 (29.6%)
  Length
    > 20 mm 23 (52.3%)
    ≤ 20 mm 21 (47.7%)

Data are presented as mean ± standard deviation, number and frequencies in parentheses, and as median and interquartile range in square brackets

Abbreviations: BMI body mass index, eGFR estimated glomerular filtration rate, CTDIvol volume computed tomography dose index, DLP dose length product, LM left main artery, LAD left anterior descending artery, LCx left circumflex artery, RCA right coronary artery